Study,InfectionVE,InfectionCI_Lower,InfectionCI_Upper,HospitalVE,HospitalCI_Lower,HospitalCI_Upper,DeathVE,DeathCI_Lower,DeathCI_Upper,Published,Start,End,Country,Design,Symptomatic,PrimarySeries,Booster
Patalon et al. (45),0.48,0.42,0.54,,,,,,,"August 31, 2021",Jan 2021,Aug 2021,Israel,TN,0,mRNA,mRNA
Andrews et al. (26),0.683,0.655,0.708,,,,,,,"November 15, 2021",Sep 2021,Oct 2021,UK,TN,1,Multiple,mRNA
Patalon et al. (46),0.58,0.56,0.61,0.91,0.86,0.94,,,,"November 30, 2021",Aug 2021,Oct 2021,Israel,TN,0,mRNA,mRNA
Andrews et al. (67) (age 19-49),0.779,0.762,0.795,,,,,,,"January 14, 2022",Sep 2021,Dec 2021,UK,TN,1,mRNA,mRNA
Andrews et al. (67) (age 50+),0.714,0.698,0.729,,,,,,,"January 14, 2022",Sep 2021,Dec 2021,UK,TN,1,mRNA,mRNA
Stirrup et al. (86),0.52,0.27,0.69,0.73,-0.34,0.95,0.86,-0.04,0.98,"August 9, 2022",Dec 2021,Mar 2022,UK,C,0,Multiple,Multiple